GovChime
Notice ID: d71bbdc8ee204dbaa55be54b570e361dAward NoticeAwarded

6505--Radiopharmaceuticals FDG and Axumin for Salt Lake City VA Medical Center

Awarded on March 30, 2022. Full description on SAM.gov.

Awarded tounder 36C25922D0041 (source: SAM.gov award notice)• $0

Overview

Posted
April 7, 2022
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of Veterans Affairs

Notice details

Place of performance
Salt Lake City VA Medical Center 500 Foothill Drive, Salt Lake City, 84148
Last updated
Dec 4, 2025
Award date
Mar 30, 2022
Award amount (SAM.gov award notice)
$0

Identifiers

Solicitation number
36C25922Q0231
Notice ID
d71bbdc8ee204dbaa55be54b570e361d
Award number (PIID)
36C25922D0041

Description

Page 2 of 2 Request for Quote (RFQ) #: 36C25922Q0231 Radiopharmaceuticals (FDG and Axumin) for the Salt Lake City VA Medical Center This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. The Government reserves the right to make no award from this solicitation. **Questions shall be submitted in writing to Matt Zorch at paul.zorch@va.gov no later than 4:00 p.m. EST, March 21, 2022 ** Quotes are to be provided to Matt Zorch at paul.zorch@va.gov no later than 4:00pm EST, March 24, 2022. Quotes shall not be hand carried. Faxed quotes shall not be accepted. Emailed quotes are the only method of submitted quotes (4MB email limit). The Government reserves the right to make award solely on initial Quotes received. Offerors bear the burden of ensuring that all portions of the offer (and any authorized amendments) reach the designated office before the deadline specified in the solicitation. This RFQ shall be completed in its entirety, and signed and dated, failure shall not be considered for award. Requirement Description: Radiopharmaceuticals for the Salt Lake City VA Medical Center located at: 500 Foothill Drive Salt Lake City, UT 84148 This is a Request for Quote (RFQ), and the solicitation number is 36C25922Q0230. The government anticipates awarding an Indefinite-Delivery Indefinite-Quantity (IDIQ) contract with firm-fixed unit pricing resulting from this solicitation. The anticipated minimum and maximum amounts for the IDIQ contract are as follows: Minimum: $10,000.00 Maximum: $2,000,000.00 This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2022-04 effective January 30, 2022. The North American Industrial Classification System (NAICS) code for this procurement is 325412 with a small business size standard of 1,250 employees. This solicitation is issued on a full and open basis. List of Line Items; See attachment titled Line Item Descriptions and Price Schedule . Description of Requirements for the items to be acquired (salient characteristics); Radiopharmaceuticals for the Salt Lake City VA Medical Center. See Statement of Work and Line Items documents for details. Delivery and acceptance is to be F.O.B Destination (FAR 52.247-34) at the Veterans Affairs Medical Center, located at 500 Foothill Drive Salt Lake City, UT 84148 52.212-1, Instructions to Offerors--Commercial ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS COMMERCIAL Gray market items are Original Equipment Manufacturer s (OEM) goods sold through unauthorized channels in direct competition with authorized distributors. This procurement is for new OEM medical supplies, medical equipment and/or services contracts for maintenance of medical equipment (i.e., replacement parts) for VA Medical Centers. No remanufactures or gray market items will be acceptable. Offeror shall be an OEM, authorized dealer, authorized distributor or authorized reseller for the proposed medical supplies, medical equipment and/or services contracts for maintenance of medical equipment (i.e., replacement parts), verified by an authorization letter or other documents from the OEM, such that the OEM s warranty and service are provided and maintained by the OEM. All software licensing, warranty and service associated with the medical supplies, medical equipment and/or services contracts for maintenance of medical equipment shall be in accordance with the OEM terms and conditions. The delivery of gray market items to the VA in the fulfillment of an order/award constitutes a breach of contract. Accordingly, the VA reserves the right enforce any of its contractual remedies. This includes termination of the contract or, solely at the VA s election, allowing the Vendor to replace, at no cost to the Government, any remanufactured or gray market item(s) delivered to a VA medical facility upon discovery of such items. Any award made as a result of this solicitation will be made on an All or Nothing Basis. State if quoted items are available and priced through offerors existing Government-wide Acquisition Contract (GWAC), GSA Multiple Award Schedule (MAS) contract, or VA-wide Acquisition Contract. If the acquisition is set-aside for SDVOSBs/VOSBs, their socioeconomic status must be VIP verified and visible in the VA Vendor Information Pages (VIP): https://www.vip.vetbiz.gov/ at the time of quote submission AND award, or will be considered non-responsive, and will NOT be considered for award. Offerors are warned against contacting any VA personnel other than the Contracting Officer and Contract Specialist prior to placement of any award made resulting from this RFQ. If such contact occurs and found to be prejudicial to competing contactors, the offeror making such contact may be excluded from award considerations. All proprietary information shall be clearly and properly marked. If the Offeror submits annexes, documentation, attachments, or the like, not specifically required by this solicitation, such will count against the Offeror s page limitations unless otherwise indicated in the specific volume instructions below. All information shall be confined to the appropriate file. The offeror shall confine submissions to essential matters, sufficient to define the quote and provide an adequate basis for evaluation. Offerors are responsible for including sufficient details, in a concise manner, to permit a complete and accurate evaluation of each quote. Submission of quote shall include the following volumes: (I) Price, (II) Narrative to Support the General and Special Standards of Responsibility Volume I Price - The offeror shall complete the pricing schedule provided in the attachment titled Line Item Descriptions and Price Schedule . The offeror shall provide pricing for: Base Period: CLINs 0001 0003 Option Period 1: CLINs 1003 1003 Option Period 2: CLINs 2001 2003 Option Period 3: CLINs 3001 3003 Option Period 4: CLINs 4001 4003 Option Period 5: CLINS 5001 - 5003 Volume II General and Special Standards of Responsibility - To assist the contracting officer in determining if the general and special standards of responsibility applicable to this procurement are met, offerors are asked to provide the following information with their quotes. Failure to include this information could result in a contracting officer s determination that an otherwise successful offeror is not eligible for contract award. General Standards of Responsibility: G1: Offeror shall provide a narrative to demonstrate they are capable of meeting the requirements identified in the Statement of Work. The narrative shall include evidence that the offeror is financially responsible and able to provide past performance evidence of their reliability, ability, experience, equipment, facilities, and personnel to provide prompt satisfactory service. The past performance evidence shall include three references for the satisfactory delivery of Radiopharmaceuticals to the Government within the last three years. Special Standards of Responsibility: SP1: Special Licensure. Offeror shall provide evidence that personnel performing work under the contract hold a License to prepare and distribute radiopharmaceuticals issued by the United States Nuclear Regulatory Commission (USNRC) or Agreement State. SP2: Special Licensure. Offeror shall employ licensed Nuclear Pharmacists to oversee daily operations. A license for each pharmacist shall be provided. SP3: Regulatory Requirements. Offeror shall meet all USNRC/Agreement State, Department of Transportation, Federal Drug Administration (FDA), Occupational Safety and Health Administration, and Pharmacy/Pharmacist Licensing requirements (Federal and State) as well as any applicable Joint Commission requirements. (End of Addendum to 52.212-1) 52.212-2, Evaluation--Commercial Items ADDENDUM to FAR 52.212-2 EVALUATION COMMERCIAL ITEMS: (a) Basis of Award. This procurement is being conducted pursuant to FAR Part13 procedures. The Government intends to award a contract resulting from this solicitation to the responsible offeror whose quote, conforming to the solicitation, quotes the lowest price, whose quoted price does not exceed the amount of funding available for the procurement, and whose quoted price is found to be reasonable. Price alone is the sole evaluation factor. In addition to the general standards of responsibility found at FAR § 9.104-1, in accordance with FAR § 9.104-2, the special standards of responsibility described below apply to this procurement. Offerors who fail to meet any special standard of responsibility will not be eligible to receive contract award. SP1: Special Licensure. Offeror shall provide evidence that personnel performing work under the contract hold a License to prepare and distribute radiopharmaceuticals issued by the United States Nuclear Regulatory Commission (USNRC) or Agreement State. SP2: Special Licensure. Offeror shall employ licensed Nuclear Pharmacists to oversee daily operations. A license for each pharmacist shall be provided. SP3: Regulatory Requirements. Offeror shall meet all USNRC/Agreement State, Department of Transportation, Federal Drug Administration (FDA), Occupational Safety and Health Administration, and Pharmacy/Pharmacist Licensing requirements (Federal and State) as well as any applicable Joint Commission requirements. (b) Evaluation Process. Quotes will be evaluated in the following manner. The lowest-priced quote will be identified. The lowest-priced quote will be evaluated to determine if the quoted price exceeds the amount of funding available for the procurement. If the quoted price does not exceed the amount of funding available for the procurement, the quoted price will be evaluated to determine if it is reasonable. If the quoted price is found to be reasonable, the offeror who submitted this quote will be identified as the successful offeror. The contracting officer will then determine if the successful offeror is responsible using the general standards of responsibility and the special standards of responsibility applicable to this procurement. If contract award cannot be made to the successful offeror, the contracting officer will evaluate the next lowest-priced quote following the procedures described above. This process will continue until a contract award can be made, or the contracting officer determines that no contract award can be made. The contracting officer may find all quotes not acceptable and cancel the solicitation if the lowest-priced quote exceeds the amount of funding available for the procurement. The contracting officer may likewise find a quote under evaluation, as well as all remaining quotes, not acceptable and cancel the solicitation if the quote currently under evaluation exceeds the amount of funding available for the procurement. The Government intends to evaluate quotes and award a contract without discussions with offerors. However, the Government reserves the right to conduct discussions at any time if determined by the contracting officer to be in the Government s interest. (c) Options. The Government will evaluate quotes for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that a quote is unacceptable if the option prices are significantly unbalanced or if the quoted price for the basic requirement or any option exceeds the amount of funding available for any of those requirements. Evaluation of options shall not obligate the Government to exercise the option(s). (End of Addendum to 52.212-2) Offerors are advised to include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications Commercial Items, with the offer. 52.212-4, Contract Terms and Conditions--Commercial Items applies to this acquisition 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders--Commercial Items FAR 52.212-5 applies to this acquisition with the following FAR clauses incorporated by reference; FAR 52.203-6 Restrictions on Subcontractor Sales to the Government (SEPT 2006), with Alternate I (OCT 1995) (41 U.S.C. 4704 and 10 U.S.C. 2402) FAR 52.204-10 Reporting Executive Compensation & First-Tier Subcontract Awards (OCT 2016) (Pub. L. 109-282) (31 U.S.C. 6101 note) FAR 52.209-6 Protecting the Government s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment (OCT 2015) (31 U.S.C. 6101 note) FAR 52.219-8 Utilization of Small Business Concerns (NOV 2016) (15 U.S.C. 637(d)(2) and (3)); FAR 52.219-28 Post Award Small Business Program Representation (Jul 2013) (15 U.S.C 632(a)(2)) FAR 52.222-3 Convict Labor (June 2003) (E.O. 11755) FAR 52.222-19 Child Labor Cooperation with Authorities and Remedies (OCT 2016) (E.O. 13126) FAR 52.222-21 Prohibition of Segregated Facilities (APR 2015) FAR 52.222-26 Equal Opportunity (SEP 2016) (E.O. 11246) FAR 52.222-35 Equal Opportunity for Veterans (OCT 2015) (38 U.S.C. 4212) FAR 52.222-36 Equal Opportunity for Workers with Disabilities (JUL 2014) (29 U.S.C. 793) FAR 52.222-37 Employment Reports on Veterans (FEB 2016) (38 U.S.C. 4212) FAR 52.222-40 Notification of Employee Rights Under the National Labor Relations Act (DEC 2010) (E.O. 13496) FAR 52.222-50 Combating Trafficking in Persons (MAR 2015) (22 U.S.C. chapter 78 and E.O. 13627) FAR 52.223-18 Encouraging Contractor Policies to Ban Text Messaging While Driving (AUG 2011) FAR 52.225 5 Trade Agreements (OCT 2016) (19 U.S.C. 2501, et seq., 19 U.S.C. 3301 note) FAR 52.225-13 Restrictions on Certain Foreign Purchases (JUN 2008) (E.O.'s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury) FAR 52.232-33 Payment by Electronic Funds Transfer System for Award Management (Jul 2013) (31 U.S.C. 3332) Additional contract requirements or terms and conditions: 52.216-18 Ordering. Ordering (Oct 1995) (a) Any supplies and services to be furnished under this contract shall be ordered by issuance of delivery orders or task orders by the individuals or activities designated in the Schedule. Such orders may be issued from April 1, 2022 through March 31, 2027. (b) All delivery orders or task orders are subject to the terms and conditions of this contract. In the event of conflict between a delivery order or task order and this contract, the contract shall control. (c)If mailed, a delivery order or task order is considered issued when the Government deposits the order in the mail. Orders may be issued orally, by facsimile, or by electronic commerce methods only if authorized in the Schedule. (End of clause) 52.216-19 Order Limitation. Order Limitations (Oct 1995) (a) Minimum order. When the Government requires supplies or services covered by this contract in an amount of less than $10,000.00 the Government is not obligated to purchase, nor is the Contractor obligated to furnish, those supplies or services under the contract. (b) Maximum order. The Contractor is not obligated to honor- (1) Any order for a single item in excess of $10,000.00. (2) Any order for a combination of items in excess of $500,000.00 or (3)A series of orders from the same ordering office within 7 days that together call for quantities exceeding the limitation in paragraph (b)(1) or (2) of this section. (c)If this is a requirements contract (i.e., includes the Requirements clause at subsection 52.216-21 of the Federal Acquisition Regulation (FAR)), the Government is not required to order a part of any one requirement from the Contractor if that requirement exceeds the maximum-order limitations in paragraph (b) of this section. (d) Notwithstanding paragraphs (b) and (c) of this section, the Contractor shall honor any order exceeding the maximum order limitations in paragraph (b), unless that order (or orders) is returned to the ordering office within 3 days after issuance, with written notice stating the Contractor s intent not to ship the item (or items) called for and the reasons. Upon receiving this notice, the Government may acquire the supplies or services from another source. (End of clause) 52.216-22 Indefinite Quantity Indefinite Quantity (Oct 1995) (a) This is an indefinite-quantity contract for the supplies or services specified, and effective for the period stated, in the Schedule. The quantities of supplies and services specified in the Schedule are estimates only and are not purchased by this contract. (b) Delivery or performance shall be made only as authorized by orders issued in accordance with the Ordering clause. The Contractor shall furnish to the Government, when and if ordered, the supplies or services specified in the Schedule up to and including the quantity designated in the Schedule as the maximum. The Government shall order at least the quantity of supplies or services designated in the Schedule as the minimum. (c) Except for any limitations on quantities in the Order Limitations clause or in the Schedule, there is no limit on the number of orders that may be issued. The Government may issue orders requiring delivery to multiple destinations or performance at multiple locations. (d) Any order issued during the effective period of this contract and not completed within that period shall be completed by the Contractor within the time specified in the order. The contract shall govern the Contractor s and Government s rights and obligations with respect to that order to the same extent as if the order were completed during the contract s effective period; provided, that the Contractor shall not be required to make any deliveries under this contract after January 31, 2026. (End of clause) 52.217-8 Option to Extend Services The Government may require continued performance of any services within the limits and at the rates specified in the contract. These rates may be adjusted only as a result of revisions to prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised more than once, but the total extension of performance hereunder shall not exceed 6 months. The Contracting Officer may exercise the option by written notice to the Contractor within 5 days of contract expiration. (End of clause) *This clause will be included as part of the evaluation. 52.217-9 Option to Extend the Term of the Contract Option to Extend the Term of the Contract (Mar 2000) (a) The Government may extend the term of this contract by written notice to the Contractor within 5 days of contract expiration provided that the Government gives the Contractor a preliminary written notice of its intent to extend at least 30 days before the contract expires. The preliminary notice does not commit the Government to an extension. (b)If the Government exercises this option, the extended contract shall be considered to include this option clause. (c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed 5 years, 6 months. (End of clause) 52.252-2, Clauses Incorporated by Reference (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es): http://www.acquisition.gov/far/index.html http://www.va.gov/oal/library/vaar/ The following FAR clauses are incorporated by reference: 52.204-7 System for Award Management The following VAAR clauses are to be incorporated by reference: 852.203-70 Commercial Advertising (JAN 2008); 852.232-72 Electronic Submission of Payment Requests (NOV 2012); 852.246-70 Guarantee (JAN 2008); 852.246-71 Inspection (JAN 2008) 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998) This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this/these address(es): http://www.acquisition.gov/far/index.html (FAR) http://www.va.gov/oal/library/vaar/index.asp (VAAR) The following FAR provisions are to be incorporated by reference: The following VAAR provisions are to be incorporated by reference: 852.273-70 Late Offers (JAN 2003); 852.273-72 Alternate Evaluation (JAN 2003); and 852.273-74 Award Without Exchanges (JAN 2003). The Defense Priorities and Allocations System (DPAS) does not apply. Date and Time offers are due to Matt Zorch at paul.zorch@va.gov by 4:00pm EST, March 24, 2022. Name and email of the individual to contact for information regarding the solicitation: Matt Zorch Paul.zorch@va.gov

Full description on SAM.gov

Award Overview

Award Number

36C25922D0041

Award Amount (SAM.gov award notice)

$0

Award Date

Mar 30, 2022

Awardee

Awardee UEI

LL8GLEVH6MG3

Awardee CAGE Code

3T624

Original Solicitation

Notice ID: d71bbdc8ee204dbaa55be54b570e361d

Posted Date: Apr 7, 2022

Original Response Deadline: Not specified

Task Orders Under This IDV

Top 10 by total obligated

10
  • 36C25925N0038
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $421.0KSigned Oct 1, 2024
  • 36C25925N0038
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $344.5KSigned Sep 15, 2025
  • 36C25925N0038
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $330.3KSigned Apr 15, 2026
  • 36C25924N0046
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $325.1KSigned Sep 27, 2024
  • 36C25924N0046
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $323.5KSigned Jan 31, 2024
  • 36C25923N0050
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $273.7KSigned Oct 1, 2022
  • 36C25924N0046
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $273.7KSigned Oct 1, 2023
  • 36C25924N0046
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $212.5KSigned Nov 10, 2025
  • 36C25926N0072
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $196.6KSigned Oct 1, 2025
  • 36C25923N0050
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $142.3KSigned Jan 24, 2024

More From This Vendor

Top 5 most recent

5
  • 36C25927N0036
    UNIVERSITY OF UTAH, THE
    Department of Veterans AffairsNAICS 325412
    $100.3KSigned Oct 1, 2026
  • 36C25925N0038
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $330.3KSigned Apr 15, 2026
  • 36C25924N0046
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $212.5KSigned Nov 10, 2025
  • 36C25926N0072
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    $196.6KSigned Oct 1, 2025
  • 36C25922D0041
    UNIVERSITY OF UTAH
    Department of Veterans AffairsNAICS 325412
    —Signed Sep 30, 2025

Contacts

Documents

No documents available.

Lifecycle

Solicitation:36C25922Q0231
  1. Combined Synopsis
  2. Awarded

This opportunity has been awarded.

  1. 2×
    Combined SynopsisMar 21, 2022

    6505--Radiopharmacetucals FDG and Axumin for the Salt Lake City VA Medical Center

    Notice f8197eeee6b44cefb61c8504b6d3f541 on SAM.gov

  2. AwardedCurrentApr 7, 2022

    6505--Radiopharmaceuticals FDG and Axumin for Salt Lake City VA Medical Center

    Notice d71bbdc8ee204dbaa55be54b570e361d on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
THIS REQUEST FOR INFORMATION (RFI) / SOURCES SOUGHT NOTICE IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES. THIS IS NOT A SOLICITATION. SUBMISSION OF INFORMATION ABOUT PRICING, DELIVERY, THE MARKET, AND CAPABILITIES IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI FOR PLANNING PURPOSES IN ACCORDANCE WITH (IAW) FAR 15.201(e). DISCLAIMER This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. SOURCES SOUGHT/RFI DESCRIPTION This is NOT a solicitation announcement. This is a Sources Sought Notice / RFI only. The purpose of this Sources Sought Notice / RFI is to gain information about potential qualified sources and their size classification relative to NAICS 325412 (size standard of 1,300 Employees). Responses to this Sources Sought Notice / RFI will be used by the Government to make appropriate acquisition decisions. After review of the responses to this Sources Sought Notice / RFI, further RFIs and/or a solicitation or other announcements may be published. The Department of Veterans Affairs (VA) is seeking sources capable of providing 18-FDG, F18 NaF, and Bulk F-18 FDG. The list of DRAFT characteristics is intended to be descriptive, not restrictive, of the supplies/services that are required. STATEMENT OF WORK (SOW) Nuclear Medicine Radiopharmaceutical Supply for FDG dose supplies. General: The Department of Veterans Affairs Loma Linda Healthcare System Nuclear Medicine service intends to set up a single award Firm Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) Contract to procure radiopharmaceutical Supplies. Period of Performance: Base: 12/15/2026 12/14/2027 Option Year 1 (OY1): 12/15/2027 12/14/2028 Option Year 2 (OY2): 12/15/2028 12/14/2029 Option Year 3 (OY3): 12/15/2029 12/14/2030 Option Year 4 (OY4): 12/15/2030 12/14/2031 Deliverables: Item Description Base Estimated Qty OY1 Estimated Qty OY2 Estimated Qty OY3 Estimated Qty OY4 Estimated Qty 18-FDG 12 mCi per dose 240 240 240 240 240 F18 NAF 10 mCi 240 240 240 240 240 Bulk F-18 FDG US (30mCi max) 4 4 4 4 4 STAT Fees (if applicable) As needed As needed As needed As needed As needed The quantities cited above chart are estimated quantities for base and all option periods; quantities are not a contractual statement of precise quantities that the Government will order. The quantities given are estimated only, and no guarantee of their accuracy is either given or implied. The Government will only pay for quantities that are actually ordered and for which the services are fulfilled. Order Limitation Minimum Order per delivery order $10,000.00 Maximum Order per delivery order $350,000.00 Radioactive agents may be Injection, USP. Able to assay the dose in a suitable dose calibrator prior to administration. Must be a sterile dose for intravenous injection. Routine Orders: Routine orders require delivery on the next business day, unless specified elsewhere in this contract. Emergency Orders: Emergency delivery requires delivery on the same day and with the time specified during the placement of order. Delivery Location, Normal Work Hours, and Instructions: Time of delivery specified or mutually agreed to at the time of receipt of telephone orders shall become mandatory upon the Contractor s acceptance to commitment. Delivery of supplies by the scheduled time will be complete except as otherwise authorized by Government personnel. If the Contractor cannot make delivery and an outside source must be utilized, the Contractor will be responsible for paying the difference in cost. VA LOMA LINDA HEALTHCARE SYSTEM Delivery Location Nuclear Medicine Section, Imaging Service. Main hospital, 4th Floor, Room 4E15, Extension 2669 or 2672. Normal Work Hours 8:00am to 4:00pm, Monday through Friday Instruction 1) Delivery shall be next business day. Unit Dose Item: For unit-dose items, products shall be pre-drawn into a syringe, calibrated and delivered at time specified when ordered. The word Dose represents the maximum size potency per unit price; however, order may be less. Packaging and Marking: The contractor shall package, mark and transfer all radioactive material in accordance with all applicable local, state, and federal regulations. Items must be adequately packaged to prevent damage during shipping, handling, and storage. All outer packages must contain the complete purchase number, obligation number and contract number in addition to the shipping address. The purchase number and obligation number will be provided by the individual at the time of ordering. The contract number will be provided upon notice of contract award. Packaging List: A packing list/slip shall be enclosed with each shipment indicating the purchase/obligation and delivery order number, contract number, items/quality ordered, and items/quality shipped. The Contractor shall provide MSDS sheets (Material Safety Data Sheets) and updates as necessary on all delivered products. Quality Assurance: The quantity of radioactivity for supplied radiopharmaceuticals will not deviate more than + or 20% for imaging doses at the time of calibration, from the quantities specified. The Contractor will perform all quality control procedures on each radiopharmaceutical according to applicable requirements of licensing authorities and other regulating bodies. A copy of the results of the quality control procedures must be made available to VALLHCS upon request. In the event that a quality control or material defect is suspected and/or detected by the Contracting Officer Representative (COR), the Contractor will be requested to provide any consultation necessary to alleviate any said suspicion and/or defect by the following: Provide technical expertise in calibration. Provide professional examination of product; submit results and recommendations to the Contracting Officer. Make expedient replacement of any product suspected of being deficient. The Contractor shall make quality control records available to VALLHCS upon written request from the Contracting Officer The Contractor must provide waste disposal at no additional charge of used radioactive dose syringes, vials, etc.; unless otherwise stipulated or prohibited by licensure or regulatory requirements. The Contractor shall provide any additional technical support deemed necessary for the technical staff, physicians, and patient education. Any recalled dose for any reason shall be credited to the Government for the full amount. Any individual doses shall be traceable to the original elution if requested by the Government as per VISN 22 pharmacy standards and regulations. Any dose deemed below standard by the facility shall be credited toward the account. This shall be determined by the Authorized User or COR. Substitutions or Generic Brands may only be used with the express permission of the facility. Items must be bar-coded and be compatible with the existing NMIS System. The Contractor shall meet all requirements of regulatory agencies for deliveries of radioactive isotopes between facilities and shall strictly adhere to these requirements. Deliveries not properly handled according to regulations will not be accepted. The Contractor shall be responsible for all costs incurred for any radiopharmaceutical and nonradioactive items contracted must find alternate supplier for the contracted items. In the event of a manufacturer or pharmacy recall or quality assurance failure, the Contractor shall notify VALLHCS Nuclear Medicine Department immediately. A radio-pharmacist in the employ of the successful Contractor must be available to: Set-up the quality assurance program on the radiopharmaceutical preparations required by Food and Drug Administration (FDA), Nuclear Regulatory Commission (NRC), United States Pharmacopeia (USP), and the Joint Commission. Act as a reference source concerning questions on the regulation of radiopharmaceuticals. Provide reference services for research drugs and radionuclides under research protocols. Provide instruction (continuing education) to the technologists on new changes in radiopharmaceutical products and availability. Contractor to provide FDG bulk dose for MEDRAD system. Contractor able to provide up to 15mCi of 18-FDG for PET patients. Recalled and Defective Products: The Contractor will immediately notify the Contracting Officer of any recalls of product or other important product safety issues. As appropriate, the Contractor will replace and/or reimburse recalled / defective products at no cost to the Government. The Contractor may be liable for costs of processing recalls, i.e. administrative and clinical services to replace recalled / defective products. Certification and Licensing Requirement: Pharmacists employed by the Contractor shall be an authorized user on the Contractor s Radioactive Materials License. The Pharmacy of the Contractor shall be licensed by the State of Operation and by the Nuclear Regulatory Commission or Agreement State Agency. Safety Guidelines and Requirements: Delivery personnel shall be trained in Radiation Safety Techniques, Nuclear Regulatory Commission, Joint Commission safety guidelines and Department of Transportation requirements. National Holidays Observed by the Government: New Year s Day January 1 Martin Luther King s Birthday 3rd Monday in January Presidents Day 3rd Monday in February Memorial Day Last Monday in May Juneteenth Day 3rd Monday in June Independence Day July 4 Labor Day 1st Monday in September Columbus Day 2nd Monday in October Veterans Day November 11 Thanksgiving Day 4th Thursday in November Christmas Day December 25th The President of the United States of America may declare additional days as a Federal holiday, and if so, this holiday will automatically be added to the list above. When a holiday falls on a Sunday, the following Monday shall be observed as a Federal holiday. When a holiday falls on a Saturday, the preceding Friday shall be observed as a Federal Holiday. Contractor Delivery Personnel: All contractor personnel are required to wear clothing bearing the name of the Contractor and wear a badge that has the Contractor name. Contractor personnel must have a picture I.D. and must be able to speak English. Parking and Speed Limit: Park only in areas designated by the Point of Contact (POC) or otherwise directed by Police and Security Service personnel. The Contractor shall display on each of its vehicles the company name in a size that is clearly visible. Upon receipt of award, the Contractor shall submit a list of employees and vehicles to the POC of each facility. The Contractor shall conform to the speed limit set at each Government facility. Should Contractor personnel receive a citation for parking, speeding or other infraction from VA Security, the offenses will be handled in Federal Court as they are Federal offenses. Placement of Verbal Orders: Contractors shall provide on a separate sheet of paper, the name, location, and telephone number of the office where the participating VA facility will call to place orders. The sheet of paper will go to the Point of Contact (POC) or alternative Point of Contact (POC). Invoice and Payment: No advanced payments will be authorized. The contractor shall submit invoices on a monthly basis. The invoice must have at a minimum, the contract number, assigned purchase order, assigned obligation number, date order was placed, date order was shipped, and any additional necessary detailed information to identify service rendered. Payment on invoice may be delayed in invoice(s) are not completed properly. Personnel Policy: The parties agree that the contract personnel working this contract shall not be considered VA employees for any purpose and shall be considered employees of the contractor. Smoking Policy: Smoking is prohibited at our facility. Security Requirements: The C&A requirements do not apply, and that Security Accreditation Package is not required. If your company is interested and capable of providing the required supplies/services, please provide the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions: (1) Submit your capabilities statement illustrating how your organization can/cannot meet the list of SOW requirements. For instances where your company cannot meet the SOW requirement(s), please explain. For instances where your company can meet the SOW requirement(s), please show how your company meets/exceeds each requirement. (2) Please review the list of SOW requirements and provide any additional feedback or suggestions. If none, please reply as N/A. (3) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc. (4) Is your company considered small under the NAICS code identified in this RFI? (5) Are you the manufacturer, authorized distributor, and/or can your company provide a solution to the required supplies/services described in the list of SOW? (6) If you are a large business, do you have any designated/authorized distributors? If so, please provide their company name, telephone, point of contact and size status (if available). (7) If you re a small business and you are an authorized distributor/reseller for the items identified above, do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified. (8) Limitations on Subcontracting: How does your business ensure compliance with the limitations on subcontracting as outlined in 13 CFR § 125.6? (9) Are the items you are identifying/providing considered Commercial of the Shelf (COTS) items as defined in FAR Part 2.101 under commercial items? (10) Non-Manufacturer Rule: If applicable, can you confirm your business complies with the Non-Manufacturer rule? Specifically, does your company: Provide a product from a small business manufacturer or processor? Not exceed 500 employees? Primarily engage in the retail or wholesale trade and normally sell the type of item being supplied? Take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice? (11) Please indicate whether your product conforms to the requirements of the Buy American Act? (12) What is your lead time to deliver a single unit with all components? Is there scale in lead time with greater quantities? Please elaborate. (13) What is estimated life span of your solution? What support/services does that entail? (14) Does your proposed equipment have FDA clearance? Please specify what FDA clearance(s) have been obtained. (15) Does your organization offer a leasing solution? Please elaborate. (16) Does your company have a Federal Supply Schedule (FSS) GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract? If so, please provide the contract number(s). (17) If you are an FSS GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract holder, are all the items/solutions you are providing information about available on your schedule/contract? Please state if all or some items are available on the contract. (18) General pricing of your products/solution is encouraged. Pricing will be used for the purpose of market research only. It will not be used to evaluate for any type of award. (19) Please provide your SAM.gov Unique Entity ID/Cage Code number. Responses to this notice shall be submitted via email to Hestia.Sim@va.gov. Telephone responses will not be accepted. Responses must be received no later than Friday, November 20, 2026, by 10AM Pacific Local Time. All responses to this Sources Sought/RFI will be used for planning purposes only. Responses to this Sources Sought Notice / RFI are not considered a request to be added to a prospective bidders list or to receive a copy of the solicitation. If further RFIs and/or a solicitation or other announcement is issued as a result of the information provided from this RFI, all interested parties must respond to the specific posting separately IAW the specifications of that announcement.
78%
Market Research11/20/2026
Page 1 AWARD NOTICE In accordance with (IAW) FAR 5.101, this notice is to advise the public that the Veterans Health Administration (VHA), Network Contracting Office 23, awarded a contract action exceeding $25,000.00 for Rh-82 Rhubidium Generators for the Iowa City VA Health Care System. The award was made to only one Federal Supply Schedule (FSS) source under the ordering procedures prescribed in GSAR Subpart 538.71, including GSAR 538.7103-3 and the sole source justification requirements at GSAR 538.7104-3(b). This notice is not a request for competitive quotations. The intended procurement is classified under North American Industry Classification System (NAICS) Code 325412. For additional information regarding this action, please contact the point of contact identified above. IAW GSAR 538.7104-3(b)(3), the redacted sole source justification for this award has been attached to this notice and made publicly available in accordance with the applicable publication requirements.
77%
AwardedOpen
Sources sought notice for VISN 2 Downstate General Radiopharmaceuticals.
76%
Market Research11/17/2026
SOURCES SOUGHT NOTICE (36C25027Q0052) Low Energy Radiopharmaceuticals (Non-FDG F-18 Agents), Unit Doses VA Northeast Ohio Healthcare System (Cleveland, OH) and VA Kent Imaging and Infusion Center (Kent, OH) Notice Type: Sources Sought (Market Research Only) Contracting Office: Department of Veterans Affairs NAICS Code: 325412 Pharmaceutical Preparation Manufacturing Small Business Size Standard: 1,300 employees Product Service Code (PSC): 6505 Drugs and Biologicals Place of Performance: Hot Lab Room B-C432, 10701 East Blvd., Cleveland, OH 44106; and Hot Lab Room B109, 3838 Cascades Blvd., Kent, OH 44240 Anticipated Period of Performance: Base: 01/01/2027 12/31/2027, plus four (4) 12-month option years (through 12/31/2031) Response Due Date/Time: 9:00 AM Eastern Time, Tuesday, November 3, 2026 to: Robert.Blasko@va.gov 1. PURPOSE / DISCLAIMER This is a Sources Sought Notice (SSN) issued for market research purposes only in accordance with FAR Part 10. It is NOT a solicitation, a request for proposal, a request for quotation, or an invitation for bid, and it does not commit the Government to issue a solicitation or award any contract. The Government will not pay for any information submitted in response to this notice, and responses will not be returned. Submitting a response does not guarantee participation in any future solicitation. The purpose of this notice is to identify qualified sources including the extent of participation by Service-Disabled Veteran-Owned Small Businesses (SDVOSBs), Veteran-Owned Small Businesses (VOSBs), and other small business concerns capable of meeting the requirement described below. Responses will assist the Government in determining the appropriate acquisition strategy (including any Veterans First / Rule of Two set-aside determination under VAAR 819.70) and will be used to support acquisition planning under FAR Part 10 and VAAR Part 810. This requirement is being conducted under the VA's health-care-resources sharing authority at 38 U.S.C. 8153 and Public Law 104-262. 2. BACKGROUND AND SCOPE The VA Northeast Ohio Healthcare System and the VA Kent Imaging and Infusion Center require unit-dose, patient-specific low energy radiopharmaceutical products (non-fluorodeoxyglucose F-18 agents) to support routine (non-emergent) and emergent diagnostic nuclear medicine imaging and limited therapeutic procedures. All doses must be compounded and calibrated by or under the supervision of a certified Nuclear Pharmacist and prepared within the required guidelines of the Board of Pharmacy, specifically USP and USP as appropriate. The contractor must follow generally accepted industry standards and the regulations of the applicable governing bodies, which may include the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the Food and Drug Administration (FDA), the Nuclear Regulatory Commission (NRC), the Centers for Disease Control and Prevention (CDC), the United States Pharmacopeia (USP), and The Joint Commission (JC). Delivery requirement: The contractor must support both routine and emergent orders (Emergencies). Emergencies may be requested during and outside of regular work hours (Monday through Friday, 06:30 a.m. 4:30 p.m.) and require delivery within 120 minutes after receipt of a phoned, faxed, or electronic order from the VA. The VA also requires prompt processing of Tc-99m tagged white blood cell (WBC) orders. Quantities are estimates and may vary based on patient demand. 3. REQUIRED LICENSURE STATEMENT Interested parties must already possess all licenses, registrations, and authorizations required to receive, possess, compound, prepare, transport, distribute, and dispose of the radioactive byproduct material / radiopharmaceutical isotopes described in this notice, and must be regularly established in the business of providing radionuclides. At a minimum, respondents must hold a current, unrevoked Nuclear Regulatory Commission (NRC) and/or applicable Agreement State radioactive materials license authorizing production and distribution of radiopharmaceuticals for human administration, and the authority to receive and dispose of radioactive waste, together with all applicable FDA, U.S. Department of Transportation (DOT), and state and local authorizations. Respondents should confirm they currently hold such licensure (and, where applicable, identify the issuing authority and license type) as part of their response. Respondents are not required to submit the full license with this SSN but must affirmatively state that current, valid licensure is in place; copies may be required at the solicitation/award stage. 4. ESTIMATED REQUIREMENT (ANNUAL ESTIMATES) The following unit-dose radiopharmaceutical products are required. Quantities are annual estimates based on historical usage for one year and may vary based on patient demand. Item Description Est. Annual Qty 1 99mTc Sulfur Colloid 320 2 99mTc MDP 850 3 99mTc Mebrofenin 110 4 99mTc MAG-3 80 5 99mTc Tetrofosmin 10 6 99mTc MAA 75 7 111In Pentreotide 2 8 99mTc04- (Sodium Pertechnetate) 90 9 99mTc Sestamibi 5,000 10 99mTc White Blood Cell Labeling 90 11 111In White Blood Cell Labeling 2 12 99mTc DTPA 30 40 mCi 60 13 99mTc DTPA 0.4 0.7 mCi 5 14 I-123 Iodine Capsules 200 microcuries 90 15 I-123 Iodine Capsules 2 5 millicuries 12 16 UltraTag Kit 22 17 99mTc Filtered Sulfur Colloid: 0.5 1 millicurie 6 18 123I MIBG dose 2 19 Cold PYP vials 50 20 99mTc PYP 100 21 99mTc DMSA 2 22 67Ga Gallium Citrate 2 23 111In DTPA 2 24 99mTc HMPAO 2 25 131I Diagnostic capsule 10 26 131I Therapeutic capsule 1 3 mCi 12 27 131I Therapeutic capsule, each additional mCi 1,500 28 99mTc HDP 55 29 99mTc WBC Blood Kit (Heparin) 90 Products must be labeled with the radiopharmaceutical identity, amount/activity, concentration, preparation time, calibration time, total volume, expiration date and time, and must include a bar-code label to facilitate scanning into a Nuclear Medicine Information System (NMIS). Each syringe, vial, syringe shield, and vial shield must be correctly labeled. 5. INFORMATION REQUESTED FROM RESPONDENTS Interested and capable firms are invited to submit a response demonstrating their ability to meet this requirement. Responses must include ALL of the following: Manufacturer Authorized Distribution Letter(s) documentation establishing the respondent's authorization to distribute the applicable radiopharmaceutical product(s) (e.g., authorized distributor/dealer letter(s) from the manufacturer(s)). Manufacturer's Name(s) identify the manufacturer(s) of the radiopharmaceutical product(s) the respondent would supply. Business Size and Socioeconomic Status state whether the firm is a large or small business under NAICS 325412 (1,300-employee size standard), and identify all applicable socioeconomic categories (e.g., SDVOSB, VOSB, 8(a), HUBZone, WOSB, SDB, or other). SDVOSBs/VOSBs must be certified in the SBA Veteran Small Business Certification program (via the SBA Search for Certified Businesses (SBS)). Ability to Provide ALL Items state clearly whether the firm can provide ALL of the items listed in Section 4. If the firm can provide only a portion, identify specifically which item(s) it can and cannot supply. GSA / NAC / SAC Availability state whether the item(s) are available on a GSA Schedule, a VA National Acquisition Center (NAC) contract, or a VA Strategic Acquisition Center (SAC) / MSPV contract vehicle, and provide the applicable contract number(s) if so. SAM Unique Entity Identifier (UEI) provide the firm's SAM.gov UEI. Respondents must be actively registered in SAM.gov (www.sam.gov). Current Licensure Confirmation an affirmative statement that the firm currently holds all required NRC and/or Agreement State, FDA, and DOT licenses/authorizations to receive, compound, prepare, transport, distribute, and dispose of the radiopharmaceutical isotopes described herein (see Section 3), including the issuing authority and license type where applicable. Positive Acknowledgement of Delivery Capability a positive, affirmative statement that the firm can deliver in accordance with ALL SOW requirements, including the ability to fulfill emergent orders within 120 minutes of receipt to both the Cleveland and Kent locations, and to provide unit doses compounded/calibrated by or under a certified Nuclear Pharmacist in accordance with USP / and all applicable NRC/FDA/DOT/state regulations. Respondents are encouraged to identify the location(s) of the radiopharmacy(ies) from which they would service both sites. Additional information requested (optional but helpful): company name, address, point of contact (name, title, phone, email); a brief capability statement; and any relevant prior experience providing unit-dose radiopharmaceuticals to federal or commercial healthcare customers. 6. SUBMISSION INSTRUCTIONS Response due date/time: 9:00 AM Eastern Time, Tuesday, November 3, 2026. Responses received after this date and time may not be considered. Format: Submit responses electronically to the Contracting Officer / Contract Specialist identified in the SAM.gov posting (Robert.Blasko@va.gov) . Reference this Sources Sought Notice number (36C25027Q0052) in the subject line. Page/content: Address each item in Section 5, in order. Capability statements should be concise. Questions: Direct any questions to the point of contact listed in the SAM.gov posting (Robert.Blasko@va.gov) prior to the response due date. 7. IMPORTANT NOTES This notice does not restrict the Government to any particular acquisition approach. Based on the responses received, the Government will determine whether the requirement can be set aside for SDVOSBs, VOSBs, or other small business concerns consistent with the Veterans First Contracting Program (VAAR 819.70) and the Rule of Two, or whether another acquisition strategy is appropriate. Respondents are advised that the Nonmanufacturer Rule (13 CFR 121.406) and Limitations on Subcontracting (FAR 52.219-14 / 52.219-33) apply to any resulting SDVOSB/VOSB set-aside or sole-source award above the micro-purchase threshold. Respondents should be prepared to address their status (manufacturer vs. nonmanufacturer) under these rules. All prospective offerors must be registered in SAM.gov to be eligible for any resulting award. The applicable Buy American Act / Trade Agreements Act provisions will apply to any resulting solicitation; respondents may be required to provide a Buy American Act certificate and country-of-origin information at the solicitation stage. THIS IS A SOURCES SOUGHT NOTICE / MARKET RESEARCH ONLY NOT A SOLICITATION.
75%
Market Research11/03/2026
75%
AwardedOpen

Additional Details

Solicitation Number

36C25922Q0231

Archive Date

May 7, 2022

Office Address

Greenwood Village, CO, 80111